(3-((Phenylamino)methyl)phenyl)boronic acid, 98%, 1g

(2E)-1-{[1,1'-biphenyl]-4-yl}-3-(4-tert-butylphenyl)prop-2-en-1-one, 95.0%, 2g

2-Nitro-4-(trifluoromethyl)benzyl bromide, 97.0%, 5g

1H-Imidazole-2-carbonitrile, 95.0%, 5g

2-(2,4-Difluorophenyl)-5-methylpyridine>98.0%(GC)(T)200mg

(S,S)-(+)-2,3-Bis(tert-butylmethylphosphino)quinoxaline>98.0%(HPLC)100mg

D-(+)-Galactose Anhydrous>98.0%(HPLC)100g

(S)-methyl 2-((tert-butoxycarbonyl)amino)-3-(4-cyano-2,6-dimethylphenyl)propanoate, 95%, 50mg

4-Hydroxy-2,6-dimethoxybenzaldehyde, 97.0%, 250mg

Sodium bis(trifluoromethanesulfonyl)imide, 98.0%, 1g

(7-Chloro-2-(2-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)benzo[d]oxazol-5-yl)methanol, 97%, 1g

Fmoc-Dap-OH, 95.0%, 10g

N-[(E)-(4-tert-Butylphenyl)methylideneamino]-4-methylbenzenesulfonamide, 95%, 100mg